clinical trials

Shire's HAE candidate boosted by new Phase 3 data
Biopharma Dive
Tue, 03/6/18 - 09:31 am
Shire
HAE
clinical trials
lanadelumab
Clearside Biomedical shares soar after eye drug succeeds in Ph3 trial
Drug Delivery Business News
Mon, 03/5/18 - 09:32 am
Clearside Biomedical
clinical trials
CLS-TA
non-infectious uveitis
Roche, Ionis herald a big win in early-stage Huntington’s disease trial, demonstrate disease modifying potential
Endpoints
Thu, 03/1/18 - 11:48 pm
Roche
Ionis Pharmaceuticals
clinical trials
Huntington's disease
IONIS-HTT Rx
This could be the next $1 billion drug, if patients get on board
Yahoo/Marketwatch
Tue, 02/27/18 - 09:55 am
sickle cell disease
Rivipansel
Pfizer
clinical trials
Lilly touts Ph3 data for once-weekly Type II diabetes medication
Drug Delivery Business News
Mon, 02/26/18 - 07:27 pm
Eli Lilly
diabetes
clinical trials
Trulicity
Beware the Lure of Early Clinical Trials Results: More Than a Third May be Exaggerated
Xtalks
Sat, 02/24/18 - 10:23 am
clinical trials
clinical trial data
Merck’s melanoma drug shows early promise for resistant cancers in PhI trial
Endpoints
Sat, 02/24/18 - 10:21 am
Merck
melanoma
clinical trials
MK-8353
In a turf war with Eli Lilly, Novo Nordisk steps off with positive PhIII for its challenging oral GLP-1 drug
Endpoints
Thu, 02/22/18 - 09:12 am
Novo Nordisk
Eli Lilly
diabetes
clinical trials
semaglutide
Trulicity
GW Pharma shares dented after cannabinoid drug fails a PhIIa study on focal seizures
Endpoints
Wed, 02/21/18 - 11:00 pm
GW Pharma
clinical trials
cannabinoids
Epidiolex
seizures
$690M deal in peril after Lilly ends mid-stage studies
Biopharma Dive
Wed, 02/21/18 - 09:43 am
Eli Lilly
clinical trials
rheumatoid arthritis
Btk inhibitors
Hanmi Pharmaceutical
LY3337641/HM71224
Peanut allergy therapy scores trial win, putting it in line to possibly become first protective treatment
Stat
Tue, 02/20/18 - 09:24 am
peanut allergy
food allergies
clinical trials
AR101
Aimmune
Eli Lilly shutters a failed PhII for rheumatoid arthritis, clouding $690M Hanmi pact
Endpoints
Mon, 02/19/18 - 11:46 am
Eli Lilly
rheumatoid arthritis
Hanmi Pharmaceutical
clinical trials
Merck KGaA, Pfizer's immunotherapy fails in lung cancer trial
Yahoo/Reuters
Thu, 02/15/18 - 10:09 am
Merck KGaA
Pfizer
lung cancer
Bavencio
clinical trials
Biogen tweaks Alzheimer’s phase 3, sparking stock slide
Fierce Biotech
Thu, 02/15/18 - 09:39 am
Biogen
Alzheimer's disease
clinical trials
aducanumab
Mid-FDA Review, Tetraphase Stumbles Again on Latest Phase 3 Setback
Xconomy
Wed, 02/14/18 - 11:43 am
FDA
Tetraphase Pharmaceuticals
clinical trials
Eravacycline
antibiotics
Madrigal shares slide despite Phase 2 success
Biopharma Dive
Sat, 02/10/18 - 09:39 am
Madrigal Pharmaceuticals
clinical trials
familial hypercholesterolemia
MGL-3196
Biogen to Discontinue Development of Stroke Drug After Early-Stage Trial Failure
Xtalks
Thu, 02/8/18 - 10:11 am
Biogen
stroke
clinical trials
natalizumab
This drug has been used to treat PTSD symptoms. What happens when it fails a trial?
Stat
Wed, 02/7/18 - 10:10 pm
PTSD
prazosin
clinical trials
Looking to grow blockbuster Pomalyst franchise, Celgene declares a win for multiple myeloma triplet in pivotal PhIII
Endpoints
Tue, 02/6/18 - 09:50 am
Celgene
Pomalyst
Multiple Myeloma
clinical trials
Data from trials could send these clinical-stage biotech stocks soaring or crashing
Motley Fool
Mon, 02/5/18 - 08:26 am
clinical trials
biotech
Summit Therapeutics
DMD
Jounce Therapeutics
JTX-2011
TG Therapeutics
ublituximab

Pages